Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension: An Open-Label, Long-Term Study

By Volpe Massimo   Miele Cristina  

Clinical Drug Investigation, Vol. 29, Iss. 6, 2009-05 ,pp. : 381-391

Adis International

Access to resources Recommend Favorite

Oxycodone Controlled-Release as First-Choice Therapy for Moderate-to-Severe Cancer Pain in Italian Patients: Results of an Open-Label, Multicentre, Observational Study

By Silvestri Barbara  

Clinical Drug Investigation, Vol. 28, Iss. 7, 2008-01 ,pp. : 399-407

Adis International

Access to resources Recommend Favorite

Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study

By Kipnes Mark S.  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 51-61

Adis International

Access to resources Recommend Favorite

Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension: A Randomized, Open-Label, Parallel-Group, Multicentre, Dose-Escalation Study with an Extension Phase

By Sica Domenic  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 825-837

Adis International

Access to resources Recommend Favorite

Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer

By Michael Michael   Gibbs Peter   Smith Robert   Godwood Alex   Oliver Stuart   Tebbutt Niall  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 253-261

Springer Publishing Company

Access to resources Recommend Favorite